Loading...
Loading...
According to a research report published this morning, BMO Capital Markets has decreased Helmerich and Payne's
HP PT from $85 to $80.
In the report, BMO Capital Markets commented, "H&P reported diluted Q2/12 EPS of US$1.18, including a US$0.05 after-tax gain from assets sales. Adjusting for these sales, EPS of US$1.13 came in below our estimate and consensus of US$1.22. Consolidated revenues of US$770 million were actually ahead of our estimate of $746 million as U.S. land revenue of US$659 million surpassed our forecast of US$630 million due to higher-than-expected average revenue per day of roughly US$30,700/day versus our forecast of US$29,400/day."
BMO Capital Markets maintains its Outperform rating on Helmerich and Payne, which is currently trading at $51.92.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in